van Beugen Boeke J, Nagaraja Raghavendra Y, Hansel Christian
Department of Neuroscience, Erasmus University Medical Center, 3000 DR Rotterdam, The Netherlands.
J Neurosci. 2006 Aug 9;26(32):8289-94. doi: 10.1523/JNEUROSCI.0805-06.2006.
Endocannabinoid signaling has been demonstrated to mediate depolarization-induced suppression of excitation at climbing fiber (CF) and parallel fiber (PF) synapses onto cerebellar Purkinje cells. Here, we show that CF-evoked release of cannabinoids (CBs) additionally suppresses a presynaptic form of long-term potentiation (LTP) at PF synapses. PF-LTP can be induced by 8 Hz PF tetanization but is blocked when the PF tetanization is paired with 4 or 1 Hz CF coactivation. CF activity can be substituted for by bath application of the CB receptor agonist WIN55,212-2 [R(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl) methanone]. In the presence of the CB1 receptor antagonist AM251 [N-1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide], CF activity no longer suppresses PF-LTP. Presynaptic potentiation can also be obtained by the adenylyl cyclase activator forskolin. WIN55,212-2 blocked this forskolin-mediated enhancement, showing that CB1 receptor activation interferes with the adenylyl cyclase-protein kinase A cascade, which participates in LTP induction. CF activity has been described to promote the induction of postsynaptic PF-long-term depression (LTD) and to impair postsynaptic PF-LTP. Our observation that CF activity blocks the induction of presynaptic LTP suggests that the CF input controls all forms of presynaptic and postsynaptic PF plasticity and that CF activity provides a "safety lock" to prevent an enhancement of transmitter release while postsynaptic AMPA receptor function is downregulated during LTD.
内源性大麻素信号传导已被证明可介导去极化诱导的对小脑浦肯野细胞上攀缘纤维(CF)和平行纤维(PF)突触处兴奋性的抑制。在此,我们表明CF诱发的大麻素(CBs)释放还会抑制PF突触处的一种突触前形式的长时程增强(LTP)。PF-LTP可通过8 Hz的PF强直刺激诱导,但当PF强直刺激与4或1 Hz的CF共同激活配对时则被阻断。CF活性可通过在浴液中应用CB受体激动剂WIN55,212-2 [R(+)-[2,3-二氢-5-甲基-3-[(吗啉基)甲基]吡咯并[1,2,3-de]-1,4-苯并恶嗪基]-(1-萘基)甲酮]来替代。在存在CB1受体拮抗剂AM251 [N-1-(2,4-二氯苯基)-5-(4-碘苯基)-4-甲基-N-1-哌啶基-1H-吡唑-3-甲酰胺]的情况下,CF活性不再抑制PF-LTP。突触前增强也可通过腺苷酸环化酶激活剂福斯可林获得。WIN55,212-2阻断了这种福斯可林介导的增强作用,表明CB1受体激活会干扰参与LTP诱导的腺苷酸环化酶-蛋白激酶A级联反应。CF活性已被描述为可促进突触后PF长时程抑制(LTD)的诱导并损害突触后PF-LTP。我们观察到CF活性会阻断突触前LTP的诱导,这表明CF输入控制着突触前和突触后PF可塑性的所有形式,并且CF活性提供了一个“安全锁”,以防止在LTD期间突触后AMPA受体功能下调时递质释放增强。